Adverse effect of parasympatholytics and spasmolytics, init

This code signifies an undesirable or harmful reaction experienced by a patient due to the therapeutic use of medications classified as parasympatholytics (anticholinergics and antimuscarinics) or spasmolytics. These drugs typically block the action of acetylcholine, affecting various bodily functions. The "initial encounter" designation indicates that the patient is receiving active treatment for the adverse effect.

Use this code when a patient presents with symptoms such as dry mouth, blurred vision, urinary retention, constipation, or tachycardia that are directly attributable to a prescribed anticholinergic or spasmolytic medication. This applies when the adverse effect is being actively managed, such as during an emergency department visit or initial hospitalization for the reaction.

• Always sequence this code after the code for the specific adverse effect (e.g., R10.9 for abdominal pain).
• Ensure documentation clearly links the adverse effect to the specific drug class (anticholinergic/spasmolytic) and confirms it was a therapeutic dose.
• For subsequent encounters related to the same adverse effect, use the appropriate subsequent or sequela encounter character.